JHOP Articles

Original Research, Leukemia, Adverse Events, Transplant

Outcomes for Patients Receiving Ibrutinib with or without Antifungal Therapy

Kori Daniels, PharmD, BCOP, Arpita S. Gandhi, PharmD, BCOP, Locke Bryan, MD, Amber Clemmons, PharmD, BCOP

Kori Daniels, PharmD, BCOP; Arpita Gandhi, PharmD, BCOP; Locke Bryan, MD; Amber Clemmons, PharmD, BCOP

Original Research, Dose Escalation/Reduction, Adverse Events, Transplant, Methotrexate

The Safety Profile of Mini-Dose Methotrexate for Graft-versus-Host Disease Prophylaxis: Is There a Place for Folinic Acid Rescue?

Loriel J. Solodokin, PharmD, BCOP, Amir Steinberg, MD, FACP, Erin Moshier, MS

Loriel J. Solodokin, PharmD, BCOP; Amir Steinberg, MD, FACP; Erin Moshier, MS

Original Research, Chemotherapy

Evaluation of Inpatient Oral Chemotherapy: An Academic Medical Center Experience

Vincent J. Cascone, PharmD, BCOP, Kane M. Hosmer, PharmD, BCOP, Zahra Mahmoudjafari, PharmD, BCOP, David W. Henry, MS, RPh, BCOP, FASHP, Dennis W. Grauer, MS, PhD

Vincent J. Cascone, PharmD, BCOP; Kane M. Hosmer, PharmD, BCOP; Zahra Mahmoudjafari, PharmD, BCOP; David W. Henry, MS, RPh, BCOP, FASHP; Dennis W. Grauer, MS, PhD

Original Research, Transplant, Vaccinations

Vaccination Rates in Patients with Hematologic Cancers After Hematopoietic Stem-Cell Transplant: A Single-Center Retrospective Study

Hiba Ahmad, PharmD, BCOP, Sarah Perreault, PharmD, BCPS, BCOP, Dayna McManus, PharmD, BCPS-AQ ID, Francine Foss, MD, Iris Isufi, MD, Stuart Seropian, MD, Jeffrey Topal, MD

Hiba Ahmad, PharmD, BCOP; Sarah Perreault, PharmD, BCPS, BCOP; Dayna McManus, PharmD, BCPS-AQ ID; Francine Foss, MD; Iris Isufi, MD; Stuart Seropian, MD; Jeffrey Topal, MD

Case Reports, Breast Cancer, Infusion Issues

Desensitization Permits Continued Trastuzumab and Ado-Trastuzumab Emtansine Therapy After Hypersensitivity Reaction

Anna Kempke, PharmD, BCOP, BCPS, Shawna Kraft, PharmD, BCOP, Mariana Castells, MD, PhD, Rajan Ravikumar, MD, Catherine Van Poznak, MD

Anna Kempke, PharmD, BCOP, BCPS; Shawna Kraft, PharmD, BCOP; Mariana Castells, MD, PhD; Rajan Ravikumar, MD; Catherine Van Poznak, MD

HOPA Abstracts

HOPA 2020 Abstracts, Part IV

FDA Updates, Prostate Cancer

FDA Approves First Prostate-Specific Membrane Antigen–Targeted PET Imaging Drug for Prostate Cancer

FDA Updates, Neuroblastoma

Danyelza First Drug FDA Approved for High-Risk Neuroblastoma in the Bone and Bone Marrow

FDA Updates, Lung Cancer

Gavreto, a New RET Inhibitor, FDA Approved for Metastatic NSCLC with RET Fusions